CNS Pharmaceuticals, Inc. (CNSP) vs Co-Diagnostics, Inc. (CODX)
A side-by-side comparison of CNS Pharmaceuticals, Inc. and Co-Diagnostics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNSP
CNS Pharmaceuticals, Inc.
$5.36HealthcareDelayed quote: Oct 6, 2026, 10:49 AM EDT
CODX
Co-Diagnostics, Inc.
$1.14HealthcareDelayed quote: Oct 6, 2026, 10:54 AM EDT
Total return — CNSP vs CODX
growth of $100 · dividends reinvested · last 7yCNSP -100.0% (-85.6%/yr)CODX -96.1% (-37.0%/yr)CODX compounded faster over this window
Log scale — wide-divergence pair
CNSP CODX
CNSP vs CODX: by the numbers
- •CNSP is the larger company ($8M vs $7M market cap).
- •Both run net losses; CNSP's is the smaller (0.00% vs -6523.04% net margin).
Metrics side by side
Valuation
| Metric | CNSP | CODX |
|---|---|---|
| P/S ratio | N/A | 9.88 |
| P/B ratio | 0.43 | 0.56 |
Profitability
| Metric | CNSP | CODX |
|---|---|---|
| Gross margin | 0.00% | 64.28% |
| Operating margin | 0.00% | -5025.53% |
| Net margin | 0.00% | -6523.04% |
| ROE | -91.75% | -370.16% |
| ROIC | -92.94% | -219.15% |
Growth (annualized)
| Metric | CNSP | CODX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -62.43% |
| Total return CAGR (5Y) | -91.63% | -66.53% |
Frequently asked
- How have CNSP and CODX total returns compared?
- Over the past 5 years, CNSP delivered -91.63% and CODX delivered -66.53% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.